Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Kat's Pathology > Plasma Cell Myeloma and Amyloid and MGUS > Flashcards

Plasma Cell Myeloma and Amyloid and MGUS Flashcards

1
Q

What are the key features of myeloma (6)

A 
Monoclonal PCs. 
Anaemia. 
Paraprotein. 
Infections. 
Kidney failure. 
Osteolytic lesions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is multiple myeloma

A

It is a cancer of transformed plasma cells, terminally differentiated B cells that secrete Ig and are the effector cells of the specific humoural immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes transformation of B cells into myeloma cells

A

Transformation results from a range of numeric and structural genetic aberrations that accumulate from a pre-malignant condition (MGUS) to terminal progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two major complications of MM

A

Bone disease.

Renal failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How common is MM

A

It is the second most common haematopoietic malignancy (after the B cell lymphomas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many people are affected by MM in the UK

A

> 4000 people every year are affected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the median survival for MM

A

4-7 years

It is debilitating and incurable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are plasma cells

A

Plasma cells are the terminally differentiated efffector cells of the specific humoural immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are mature plasma cells formed (4)

A 
Encountering antigen drives a virgin B cell to generate a low-affinity plasma cell or stimulates its migration to a germinal centre. 
In the germinal centre, affinity maturation occurs and is mediated through two processes: somatic hypermutation and antigen selection. 
Subsequently, class switch recombination occurs, leading to the development of immunoglobulin (Ig) isotypes. 
Once this process is complete, the plasmablast leaves the germinal centre and migrates to the bone marrow where it becomes a long-lived plasma cell that produces antibody.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What cell in the body secretes the most proteins

A

Plasma cells secrete more proteins than any other cell (up to 10,000lg molecules/second)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pathogenesis of MM

A

Genetic instability leads to monoclonal gammopathy of undetermined significance (MGUS).
1%/year of these transform to MM due to genetic alterations and changes in the bone marrow microenvironment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What genetic instability occurs to generate MGUS (2)

A

Translocations at 14q32 (50%)

Deletion of chromosome 13 (50%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What genetic defects need to occur for MGUS to transform to MM (3)

A

N-RAS, K-RAS (30%)
p16 Methylation (40%)
Secondary translocations?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What changes occur in the bone marrow microenvironment to contribute to malignancy change of MGUS to MM (2)

A

Increased bone resorption

Increased angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What karyotype suggests better prognosis in MM

A

55-60% of patients have a hyperdiploid karyotype, which gives a better prognosis than those with non-hyperdiploid disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the evolution of MM

A

Post-germinal centre B cell –> MGUS –> smouldering myeloma –> myeloma –> plasma cell leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the symptoms of MM (6)

A 
Back pain. 
Fatigue 
Acute renal failure 
Pneumonia 
Paralysis - cord compression 
Abnormality on routine lab test
18
Q

What is the pneumonic to remember the clinical signs of MM

A

CRAB

19
Q

What does CRAB stand for

A

Calcium elevated
Renal impairment
Anaemia
Bone lesions

(and monoclonal proteins)

20
Q

What is the median age at diagnosis of MM

A

65-70 years

21
Q

What is the medial survival for MM patients

A

3-4 years (6-10 years in patients fit for intensive treatment)

22
Q

What proportion of blood cancers does MM constitute

A

15%

23
Q

What is the incidence of MM

A

5/100,000/year

24
Q

What groups of people are at increased risk of MM (4)

A

Farmers, laxative takers, cosmetologists, radiologists.

25
Q

Exposure to what increases MM risk (4)

A

Asbestos, petrolium products, pesticides, rubber/wood products

26
Q

What condition may predispose to MM

A

Chronic infection/inflammatory conditions

27
Q

What is the cell morphology of mature myeloma cells (4)

A

Clumped chromatin
Low nuclear-cytoplasmic ratio.
Abundant cytoplasm.
Rare nucleoli.

28
Q

What are MM positive for in immunophenotypeing (4)

A

CD38
CD138
CD56/58
Monotypic cytopasmic Ig

29
Q

What do MM cells lack (immunophenotyping) (3)

A

CD19
CD20
Surface Ig

30
Q

What does myeloma bone disease consist of (5)

A

80-90% of patients with myeloma have lytic lesions (or low bone density)
20% have pathological fractures at diagnosis, up to 60% at some point.
Spinal cord compression (paralysis)
Hypercalcaemia (renal failure)
Bone pain (mobility, independence, quality of life)

31
Q

What are some osteoclast activating factors (4)

A

RANK-L
TNFalpha
IL-6
IL-3

32
Q

What are some osteoblast inhibiting factors (4)

A

Dkk-1
HGF
Sclerostin
sFRP3

33
Q

What is the best imaging to detect myeloma bone disease

A

MRI

High sensitivity for marrow infiltration
Response monitoring possible
Expensive and limited availability

34
Q

What is the more realistic imaging used for MM

A

CT

Detects very small lesions
Good for radiotherapy planning
Higher radiation dose

35
Q

What would the ideal imaging technique for MM detection

A

PET

Detects active disease
High costs, limited availability

36
Q

How does MM cause kidney injury (3)

A

Inflammatory mediations are activated in the proximal tubule epithelium.
This leads to proximal tubule necrosis.
Fanconi syndrome (renal tubule acidosis) with crystal deposition (FLC)

37
Q

What are the treatment options available for MM (4)

A

Steroids
Classical Cytostatic drugs (melphalan)
Proteasome inhibitors
IMIDs (thalidomide, lenalidomide, pomalidomide)

38
Q

How does melphalan work

A

Nitrogen mustart-type alkylating agent

Adds alkyl group to DNA (guanine) –> crosslinkes G/blocks DNA replication.

39
Q

How is melphalan used for MM (3)

A

Stem ell collection from the blood and storage
High-side melphalan to kill myeloma cells
Re-infusion of stem cells to rescue blood formation

40
Q

How do proteasome inhibitors work

A

Proteins are folded within the cell by the ER.
Misfolded proteins can cause cell stress, so they are recycled by proteasomes.
Inhibition of proteasomes cause fatal ER strass and intracellular amino acid starvation.

41
Q

How does thalidomide work in MM

A

The small molecule drug binds to the protein CRBN, which activates the enzymatic activity of the CRBN E3 ubiquitin ligase complex.
The transcription factors IKZF1 and IKZF3 are modified with ubiquitin molecules, targeting then for proteolysis.
This alters the function of the T cells and B cells, with a toxic outcome for MM cells.

Kat's Pathology (105 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions